← Leaderboards
Marintha Heil
Southern Research Institute
$15,630,797
Attributed
$15,630,797
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.5M · FY2010–14$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$15,630,797 · 2
By mechanism
N01$15,630,797 · 2
Top collaborators
No co-investigators on record.
Most similar at Southern Research Institute
Same institution · by research overlap
- Robert Walter Buckheit$12,955,650
- Roger Ptak$24,583,615
- Susan Schader$3,647,128
- Patricia E Noker$6,161,476
- Rose Hood$20,384,784
Others in their field
Top investigators on “Biochemical”
- Michael W Weiner · Northern California Institute Res &Educ$74,211,055
- Bruce W Stillman · Cold Spring Harbor Laboratory$47,787,987
- John Damon Chodera · Sloan-Kettering Inst Can Research$47,159,667
- Nanduri R Prabhakar · Case Western Reserve University$46,495,566
- Richard C Boucher · University Of North Carolina Chapel Hill$44,019,683
- Peter D Karp · Sri International$43,901,053
Research focus
BiochemicalCellsBaseLocal MicrobicidesNovel TherapeuticsSourcePublic Health Medicine (Field)Phase I Clinical TrialsResearch PersonnelPrivate SectorPublic Health PrioritiesContractsAcademiaProspectiveInvestigational New Drug ApplicationServicesPre-ClinicalProduct DevelopmentFundingNational Institute Of Allergy And Infectious DiseaseHigh Throughput ScreeningIn VitroMicrobicideAcquired Immunodeficiency Syndrome
Grant awards (13)
IN VITRO SCREENING OF INTERVENTIONAL AGENTS IN HTS FORMATS: 700,000 COMPOUND SCREEN OF VIF/APOBEC INHIBITORS$849,913
N01 · FY2014 · AI · contact PI
Conduct Hit-To-Lead Progression Studies on Interventional Agents$381,094
N01 · FY2014 · AI · contact PI
CONDUCT HIT-TO-LEAD PROGRESSION STUDIES ON INTERVENTION AGENTS: VIF/APOBEC INHIBITORS$351,658
N01 · FY2014 · AI · contact PI
CONDUCT HIT-TO-LEAD PROGRESSION STUDIES ON INTERVENTION AGENTS: VIF DIMERIZATION INHIBITORS$351,658
N01 · FY2014 · AI · contact PI
In Vitro Confirmatory Testing and Screening of Interventional Agents in Standard Formats$275,547
N01 · FY2014 · AI · contact PI
ADMINISTATION AND DATA COORDINATION: ANNUAL UPDATE OF THE NCBI DATABASE$263,806
N01 · FY2014 · AI · contact PI
In Vitro Screening of Interventional Agents in High Throughput Screening (HTS) Formats$252,788
N01 · FY2014 · AI · contact PI
Develop New In Vitro Assays$160,422
N01 · FY2014 · AI · contact PI
Administration and Data Coordination$119,593
N01 · FY2014 · AI · contact PI
In Vitro Testing Resources for AIDS Therapeutics Dev: Specialized Assays$3,174,946
N01 · FY2013 · AI · contact PI
In Vitro Testing Resources for AIDS Therapeutics Dev: Specialized Assays$3,179,659
N01 · FY2012 · AI · contact PI
In Vitro Testing Resources for AIDS Therapeutics Dev: Specialized Assays$3,467,128
N01 · FY2011 · AI · contact PI
Award of Part B - In Vitro Testing Resources for AIDS Therapeutics Development$2,802,585
N01 · FY2010 · AI · contact PI